Novartis CEO reportedly weighing U.S. price cuts as Trump’s MFN deadline nears Novartis CEO reportedly weighing U.S. price cuts as Trump’s MFN deadline nears Post Contentnvs, nvsefRead More You might also be interested in reading SEC Likely to Approve Bitcoin Futures ETF Next Week. September 20, 2025 In Mainstream ← Previous post Next post →